Personal information

No personal information available

Activities

Collapse all

Works (10)

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy

European Journal of Cancer
2024-11 | Journal article
DOI: 10.1016/j.ejca.2024.115055
Part of ISSN: 0959-8049
Contributors: Rachel Woodford; Janet McKeown; Lotte L. Hoeijmakers; Johanna Mangana; Florentia Dimitriou; Clara Allayous; Farzana Zaman; Francisco Aya; John Marsiglio; Rachel Goodman et al.
Source: Self-asserted source
Farzana Yasmin Zaman

Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases

Clinical and Translational Medicine
2024-04 | Journal article
DOI: 10.1002/ctm2.1657
Part of ISSN: 2001-1326
Part of ISSN: 2001-1326
Contributors: Imogen Walpole; Farzana Y Zaman; Peinan Zhao; Vikki M. Marshall; Frank P. Lin; David M. Thomas; Mark Shackleton; Albert A. Antolin; Malaka Ameratunga
Source: Self-asserted source
Farzana Yasmin Zaman

Nature and management of melanoma recurrences following adjuvant anti-PD-1 (PD1) therapy.

Journal of Clinical Oncology
2023-06-01 | Journal article
DOI: 10.1200/jco.2023.41.16_suppl.9575
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Rachel Woodford; Janet McKeown; Lotte Hoeijmakers; Joanna Mangana; Celeste Lebbe; Farzana Yasmin Zaman; Francisco Aya; John Marsiglio; Rachel S Goodman; Victoria Rayson et al.
Source: Self-asserted source
Farzana Yasmin Zaman

Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis

Cancers
2023-04-23 | Journal article
DOI: 10.3390/cancers15092425
Contributors: Farzana Y. Zaman; Ashwin Subramaniam; Afsana Afroz; Zarka Samoon; Daniel Gough; Surein Arulananda; Muhammad Alamgeer
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies

British Journal of Cancer
2022-11-09 | Journal article
DOI: 10.1038/s41416-022-01882-8
Contributors: Farzana Y. Zaman; Suzanne G. Orchard; Andrew Haydon; John R. Zalcberg
Source: check_circle
Crossref

Dramatic clinical response in the treatment of small cell glioblastoma multiforme

Journal of Clinical Pharmacy and Therapeutics
2022-06 | Journal article
DOI: 10.1111/jcpt.13608
Contributors: Farzana Yasmin Zaman; Catriona McLean; Malaka Ameratunga
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy

Journal for ImmunoTherapy of Cancer
2021-10 | Journal article
DOI: 10.1136/jitc-2021-003066
Part of ISSN: 2051-1426
Contributors: Briana Halle Brady; Allison Betof Warner; Farzana Y Zaman; Andrew Haydon; Prachi Bhave; Anna K Dewan; Fei Ye; Rebecca Irlmeier; Paras Mehta; Nicholas R. Kurtansky et al.
Source: Self-asserted source
Farzana Yasmin Zaman

Cost‐analysis of opportunistic influenza vaccination in general medical inpatients

Internal Medicine Journal
2021-04 | Journal article
DOI: 10.1111/imj.15270
Part of ISSN: 1444-0903
Part of ISSN: 1445-5994
Contributors: Daniel C. Darmaputra; Farzana Y. Zaman; Yin Li Khu; Vathy Nagalingam; Danny Liew; Ar Kar Aung
Source: Self-asserted source
Farzana Yasmin Zaman

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

Annals of Oncology
2020-08 | Journal article
DOI: 10.1016/j.annonc.2020.04.471
Part of ISSN: 0923-7534
Contributors: C.N. Owen; A.N. Shoushtari; D. Chauhan; D.J. Palmieri; B. Lee; M.W. Rohaan; J. Mangana; V. Atkinson; F. Zaman; A. Young et al.
Source: Self-asserted source
Farzana Yasmin Zaman

Opportunities to improve influenza vaccination rates in general medical inpatients

Internal Medicine Journal
2019-05 | Journal article
DOI: 10.1111/imj.14275
Contributors: Farzana Y. Zaman; Vathy Nagalingam; Chloe Wong; Yin Li Khu; Hui Wen G. Teng; Jyotsna Janardan; Edward Ritchie; Allen C. Cheng; Ar Kar Aung
Source: check_circle
Crossref
How many people are using ORCID?